Introduction
Natural killer (NK) cells are part of the innate arm of the immune system. Their function is to eliminate aberrant cells, including virally infected and tumorigenic cells. For this purpose NK cells store cytotoxic proteins within secretory lysosomes, specialized exocytic organelles that are also known as lytic granules. Analogous to an assassin pulling the trigger of his gun, the recognition of an aberrant target cell activates the polarized exocytosis of secretory lysosomes releasing cytotoxic molecules that kill the target cell. To understand the cytotoxic function of NK cells it is, therefore, important to determine how secretory lysosomes are mobilized to release their cytotoxic contents. Recently, significant progress has been made in understanding the molecular basis for secretory lysosome exocytosis in NK cells. In particular, the characterization of immune disorders in which NK cytotoxicity is impaired has led to the identification of novel components of the exocytic machinery (Table 1) . These immune disorders also highlight the essential role that secretory lysosome exocytosis plays in NK cell cytotoxicity and demonstrate that the loss of the exocytic activity of NK cells has profound immunological consequences. This review summarizes these findings and highlights areas where our understanding of secretory lysosome exocytosis is limited.
NK cells and cytotoxic T lymphocytes: brothers in arms
(MHC) class I molecules. 1, 2 Not surprisingly, the cell surface expression of MHC class I is often down-regulated by tumours and virus-infected cells, enabling these cells to escape CTL killing. 3, 4 However, NK cells can recognize and kill cells that have down-regulated MHC class I molecules from their cell surface. [5] [6] [7] The MHC class I molecules are recognized by NK cell inhibitory receptors and the ligation of these receptors inhibits the activation of NK cells. Conversely the lack of engagement of these receptors can activate NK cytotoxicity. [5] [6] [7] In addition, NK cells recognize other signals associated with aberrant cells. Viral infection and malignant transformation of cells can induce the expression of the MHC class I chain-related (MIC) molecules MICA and MICB as well as the UL16-binding proteins. 8 These molecules are recognized by the NK cell activating receptor NKG2D and ligand binding by this receptor can signal target cell killing. [5] [6] [7] [8] The natural cytotoxicity receptors (NCRs) represent a second class of activating receptors and include NKp46, which binds to influenza haemagglutinin. 9 Furthermore, NK cells express the low-affinity IgG receptor CD16, which enables them to recognize and kill target cells opsonized with antibodies by antibody-dependent cell-mediated cytotoxicity. [5] [6] [7] Yet despite the profound differences in how they recognize virus-infected and tumorigenic cells, secretory lysosome exocytosis is required for target cell killing by both NK cells and CTLs.
Pulling the trigger: secretory lysosome exocytosis
Secretory lysosomes are dual function organelles that combine the degradative function of conventional lysosomes with the capacity to undergo regulated exocytosis. [10] [11] [12] The major cytotoxic proteins contained within secretory lysosomes in NK cells and CTLs are the granzymes and perforin. [12] [13] [14] Target cell recognition induces secretory lysosome exocytosis and the release of the cytotoxic contents of this organelle. Perforin then facilitates the entry of the granzymes into the target cell cytoplasm, where they cleave a variety of targets, such as caspases, resulting in cell death. 15, 16 To ensure that NK cells do not kill indiscriminately, the exocytosis of secretory lysosomes is a tightly regulated and highly ordered process. For the purposes of this review it can be divided into four stages (Fig. 1) . First, an activating, lytic immunological synapse forms at the point of contact with the target cell, and there is a rearrange- [23] [24] [25] [26] [27] WASp Interacting protein (WIP)
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Griscelli syndrome 2 (GS2) [40] [41] [42] [43] [44] [45] [46] [47] Myosin Stage 1: Formation of a lytic immunological synapse and reorganization of the actin cytoskeleton
Upon recognition of a target cell, a lytic synapse develops at the point of contact between the target and the NK cell (Fig. 1a) . [17] [18] [19] Imaging experiments demonstrate that the NK lytic synapse can be divided into two distinct domains. [17] [18] [19] The peripheral supramolecular activation cluster (pSMAC) forms a ring at the point of contact and contains adhesion molecules including lymphocyte function-associated antigen 1 (LFA-1, CD11a/CD18). The central SMAC (cSMAC) is found within this ring and is thought to be the focal point for the exocytosis of secretory lysosomes, allowing them to release their content towards the target cell. Indeed, this is analogous to the lytic synapse formed between a CTL and its target, in which the cSMAC also corresponds to the site of secretory lysosome exocytosis. 10, 19 As such, the polarized exocytosis of secretory lysosomes at the lytic synapse represents an important functional specialization of cytotoxic cells, as it is predicted to enable NK cells and CTLs to kill aberrant cells, while normal cells that are in close proximity remain unharmed.
In addition to acting as the focus of secretory lysosome exocytosis, the lytic synapse is the major site of NK receptor signalling that is initiated upon target cell recognition. 17 Little is known about how NK receptor signalling cascades integrate with the polarized exocytosis of secretory lysosomes, although multiple signals may be required. For example, interaction of intercellular adhesion molecule 1 (CD54) with its NK cell ligand LFA-1 induces the polarization of secretory lysosomes to the lytic synapse, but not their exocytosis. 20 Conversely, binding of the NK receptor CD16 to IgG on opsonized target cells induces exocytosis, but not secretory lysosome polarization. 20 Actin polymerization and cytoskeletal reorganization at the lytic synapse are required for secretory lysosome exocytosis. Disruption of actin cytoskeletal rearrangements, such as inhibition of actin polymerization or depolymerization by treatment with cytochalasin D and jasplakinolide, respectively, blocks NK cytotoxicity and impairs the mobilization of secretory lysosomes to the lytic synapse. 18, 21, 22 This cytoskeletal reorganization involves the accumulation of filamentous-actin (F-actin) in the pSMAC region of the lytic synapse, whereas the cSMAC is largely free of actin, enabling secretory lysosomes to come into intimate contact with the plasma membrane in this region. 17, 18 The Wiskott-Aldrich syndrome protein (WASp) is required for the rearrangement of actin at the lytic synapse. 18, 23 Expression of WASp is restricted to cells of the haemopoietic lineage and it acts on the actin cytoskeleton through the Arp2/3 complex, to induce actin nucleation and branching. 24 The gene encoding WASp is mutated in the immune disorder Wiskott-Aldrich syndrome (WAS) and NK cells isolated from these patients show a reduced ability to kill target cells, although this effect is often compensated for by increased numbers of NK cells. [23] [24] [25] WASp co-localizes with F-actin at the lytic synapse, and correspondingly in NK cells lacking functional WASp, F-actin accumulation at the lytic synapse and secretory lysosome polarization are both diminished. 23, 26 Furthermore, the ability of NK cells from WAS patients to form conjugates with target cells is reduced, suggesting that this process also requires actin polymerization. 26 WASp is regulated by the GTPase Cdc42, which in its GTP bound form binds to WASp inducing a conformational change that allows WASp to interact with the Arp2/3 complex and initiate actin polymerization. 24 Crucially target cell recognition by NK cells promotes GTP binding by Cdc42, suggesting that WASp acts as an interface between NK receptor signalling pathways and secretory lysosome exocytosis. 26 Furthermore, and consistent with this notion, WASp is tyrosine phosphorylated in activated NK cells, which may also promote its ability to stimulate actin polymerization.
26,27
Stage 2: Polarization of the MTOC and secretory lysosomes to the lytic synapse
In the next stage of secretory lysosome exocytosis, the MTOC and secretory lysosomes polarize towards the lytic synapse (Fig. 1b) . This process must be co-ordinated with the formation of the lytic synapse and the reorganization of the actin cytoskeleton. Two proteins that interact with WASP may play this role, namely WASp interacting protein (WIP) and Cdc42 interacting protein-4 (CIP4). [28] [29] [30] WIP is associated with secretory lysosomes and upon NK cell activation it polarizes with WASP towards the lytic synapse. 30 At this site, in the human NK cell line YTS, WIP and WASp form a complex with F-actin and Myosin IIa, which is dependent on protein kinase C-h activation of WIP. 29 The precise role of WIP and this complex are not known, although depletion of WIP by RNA interference (RNAi) leads to loss of cytotoxicity. 30 Intriguingly, whereas WIP depletion has only a minor effect on F-actin accumulation at the lytic synapse, secretory lysosomes are unable to polarize to the lytic synapse in WIP-deficient cells. 30 Together these observations suggest that WIP may play a role in linking actin cytoskeletal changes to the later stages in secretory lysosome exocytosis.
Likewise CIP4 may link the reorganization of the actin cytoskeleton and the movement of the MTOC to the lytic synapse. CIP4 interacts with the microtubule component a-tubulin in the human NK cell line YTS. 28 On activation, CIP4 is polarized to the lytic synapse, where it colocalizes with the MTOC and interacts with WASp. 28 Moreover, depletion of CIP4 by RNAi inhibits MTOC polarization and reduces the cytotoxicity of the YTS cells, but CIP4 depletion has no effect on F-actin accumulation at the lytic synapse. 28 The implication is that CIP4 acts after the reorganization of F-actin, to facilitate the movement of the MTOC to the lytic synapse.
Movement of the MTOC to the lytic synapse is thought to be a prerequisite for the polarization of secretory lysosomes. Indeed, if NK cells cannot polarize the MTOC to the lytic synapse then secretory lysosomes also fail to become polarized to this site. 31, 32 In CTLs, and presumably in NK cells, secretory lysosomes are transported along microtubules in a minus-end direction from the cell periphery to the MTOC. 33 As the MTOC moves to the lytic synapse, this brings secretory lysosomes into close proximity with the plasma membrane, and in CTLs the MTOC contacts the plasma membrane. 33 The motor proteins required to transport secretory lysosomes to the lytic synapse in NK cells are unknown, although the adaptor protein 3 (AP-3) complex is required for this step in CTLs. 34 The b-subunit of the AP-3 complex is mutated in the immune disorder Hermansky-Pudlak syndrome subset 2 (HPS2) and correspondingly CTLs and NK cells isolated from HPS2 patients have reduced cytotoxicity. 10, 34, 35 In HPS2 CTLs, the secretory lysosomes are enlarged and unable to move along microtubules towards the MTOC and lytic synapse. 34 Precisely why the AP-3 complex is required for secretory lysosome exocytosis is unclear, although in other cells the AP-3 complex functions in protein sorting to conventional lysosomes. 36 The reduction in exocytosis may, therefore, be secondary to a defect in secretory lysosome formation. Indeed, the secretory lysosome protein CD63 is mis-sorted to the plasma membrane in HPS2 CTLs. 34 One intriguing possibility is that AP-3 may sort one or more proteins to secretory lysosomes that are required for the movement of this organelle to the lytic synapse.
Another protein that may play a role in the movement of secretory lysosomes to the lytic synapse is the small GTPase Rab7, which was identified in secretory lysosome fractions from the human NK cell line YTS by proteomic analysis. 37 Rab7 is involved in the movement of conventional lysosomes, in a minus-end direction, along microtubules, through its effector Rab7 interacting lysosomal protein (RILP), which recruits dynein-dynactin motor complexes to lysosomes. 38, 39 Furthermore, and consistent with a role for Rab7 in the movement of secretory lysosomes, over-expression of RILP in CTLs promotes clustering of secretory lysosomes around the MTOC. 33 The role of Rab7 and RILP in NK cells is unknown, but clearly warrants investigation.
Stage 3: Docking of secretory lysosomes with the plasma membrane Docking of secretory lysosomes with the plasma membrane precedes the fusion of these two membranes (Figs 1c and 2a) , and in CTLs this requires the small GTPase Rab27a. 40 The gene encoding Rab27a is mutated in the immunodeficiency Griscelli syndrome 2 (GS2), and in Ashen mice, which results in severely reduced cytotoxic activity in CTLs. [40] [41] [42] [43] In CTLs that lack functional Rab27a, secretory lysosomes cluster around the MTOC, but are unable to fuse with the plasma membrane. 40 Rab27a is localized to the late endosomes of CTLs, although upon activation by target cell recognition it becomes co-localized with secretory lysosomes at the lytic synapse. 44 Although initial reports demonstrated that Rab27a is required for NK cell cytotoxicity, this GTPase is dispensable under certain circumstances for secretory lysosome exocytosis in NK cells. 43, [45] [46] [47] Target cell killing activated by CD16 is unaltered in GS2 NK cells, although cytotoxicity induced by the NCR receptor NKp30 is impaired in the same cells. 46 This suggests that there are both Rab27a-dependent and -independent pathways for exocytosis in NK cells. The closely related GTPase Rab27b has also been detected in NK cells by microarray analysis, raising the possibility that Rab27b could play a complimentary role to Rab27a in NK cell secretory lysosome exocytosis. 48 Indeed, these proteins may have some degree of functional redundancy, as mast cells from the double Rab27a/Rab27b knockout mice have a greater defect in regulated exocytosis than those from either of the individual knockouts. 49 Myosin IIa may also play a role in the later stages of secretory lysosome exocytosis. This protein is recruited by WIP to a WASp-WIP-F-Actin complex at the lytic synapse on NK cell activation.
29 Surprisingly, considering its early recruitment to the lytic synapse, depletion or inhibition of myosin IIa has no effect on movement of either the MTOC or secretory lysosomes to the lytic synapse. 50 However, secretory lysosomes are unable to fuse with the plasma membrane and cytolytic activity is severely impaired. 50, 51 The precise role of myosin IIa is unclear, although it may act to move secretory lysosomes from around the MTOC into close apposition with the plasma membrane.
Stage 4: Fusion of secretory lysosomes with the plasma membrane
To release their cytotoxic contents, the secretory lysosomes mobilized to the lytic synapse must fuse with the plasma membrane (Figs 1d and 2c) . Fusion between two cellular membranes in the exocytic and endocytic pathways is catalysed by soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs). 52 SNAREs have a modular structure comprising one or two SNARE domains, varying N-terminal domains and either a transmembrane domain or a lipid tail to anchor them to a membrane. A SNARE complex is formed when four SNARE domains come together across two membranes to form a four-helical bundle, bringing the membranes into close proximity and driving their fusion (Fig. 2c) . 52 The Rab27a binding partner Munc13-4 is required immediately before fusion of secretory lysosomes with the plasma membrane in CTLs and it may perform the same function in NK cells (Fig. 2b) . 44, 53, 54 Munc13-4 is mutated in familial haemophagocytic lymphohistiocytosis subset 3 (FHL3) and both NK cells and CTLs isolated from these patients have reduced cytotoxicity. [53] [54] [55] Analysis by electron microscopy has revealed that in FHL3 CTLs cells secretory lysosomes can dock at the plasma membrane, but do not fuse. 54 Munc13-1, the neuronal homologue of Munc13-4, primes vesicles for fusion by releasing syntaxin 1A from Munc-18, allowing syntaxin 1A to form a functioning SNARE complex and so induce fusion.
56 Munc13-4 may perform a similar function in NK cells and CTLs, priming SNARE-mediated fusion.
The SNAREs responsible for secretory lysosome fusion with the plasma membrane in NK cells are poorly defined, although syntaxin 11 is required for the exocytosis of secretory lysosomes in these cells. [57] [58] [59] [60] This SNARE is mutated in FHL subset 4 (FHL4), and NK cells isolated from FHL4 patients, or in which syntaxin 11 expression has been depleted by RNAi, have severely impaired secretory lysosome exocytosis and correspondingly are unable to kill target cells. [57] [58] [59] [60] Surprisingly, in NK cells this SNARE is associated with cytoplasmic puncta that are distinct from the secretory lysosomes and the plasma membrane. 37 As such, the requirement of syntaxin 11 for secretory lysosome exocytosis is puzzling. However, in macrophages, which also express syntaxin 11, this SNARE is mobilized to the plasma membrane during phagocytosis. 61 One intriguing possibility is that syntaxin 11 may be recruited to the exocytic site upon NK cell activation whereupon it may promote membrane fusion. Syntaxin 11 is not an absolute requirement for secretory lysosome exocytosis in NK cells, as both secretory lysosome exocytosis and cytotoxicity in cells isolated from FHL4 patients can be partially restored after culturing the cells for 2-3 days in high levels of interleukin-2 (IL-2). 60 The implication is that there may be an alternative syntaxin-11-independent pathway that is up-regulated in NK cells by IL-2. Indeed, syntaxin 11 is not consistently detected in CTLs, which presumably can also use a syntaxin-11-independent pathway for secretory lysosome exocytosis. 60 In addition to syntaxin 11, other SNAREs will be required for secretory lysosome exocytosis. The SNAREs vesicle-associated membrane protein 7 (VAMP7) and syntaxin 7 are both localized, at least in part, to NK cell secretory lysosome membranes. 37 The role of syntaxin 7 in NK cells has not been defined, but RNAi knockdown of VAMP7 inhibits granzyme B release and target cell killing by the NK cell line YT-Indy. 62 These data suggest that VAMP7 is required for a membrane fusion reaction that either occurs during secretory lysosome exocytosis or that is required for the delivery of proteins to this organelle. More work is, however, needed to determine whether any of the aforementioned SNAREs form part of the trans-SNARE complex that drives fusion of the secretory lysosome with the plasma membrane.
Replenishing the NK cell secretory lysosome arsenal
Little is known about what happens after the fusion of secretory lysosomes with the plasma membrane. Are secretory lysosomes retained, as in the 'kiss and run' model of neuronal vesicle fusion, or do they become incorporated into the plasma membrane? 63 NK cells are able to kill an average of four target cells each, but appear to become 'exhausted' after this and have diminished perforin and granzyme B levels. 64 Treatment with IL-2 can replenish the cells' cytotoxicity after 48 hr, presumably through increased expression of new perforin and granzymes, whose levels increase again. 64 It is not clear from this work whether the secretory lysosomes themselves are lost and replenished, or simply their content. Not surprisingly, little is known about the machinery involved in the replenishment of secretory lysosomes or their content, although dynamin 2 may be involved. Dynamin 2 is a large GTPase that is required for cytotoxicity in NK cells. 65 In cells in which dynamin 2 is inhibited using a chemical inhibitor, or depleted by RNAi, secretory lysosomes polarize to the lytic synapse but fusion with the plasma membrane is reduced, suggesting that dynamin 2 may play a role in the late stages of secretory lysosome exocytosis. In other cell types dynamin has been found to play a role in secretory granule recapture and in membrane fission. 66, 67 Dynamin 2 may play an analogous role in recapture of secretory lysosomes from the plasma membrane, and promote exocytosis by removing spent secretory lysosome membranes from the secretory domain so that new ones can dock. 65 Unable to pull the trigger: the immunological consequences of mutations in the NK cell exocytic machinery
As outlined above, NK cell cytotoxicity is severely impaired in cells that have mutations in proteins that are required for secretory lysosome exocytosis ( Table 1 ). The consequences of the resultant loss in NK cell cytotoxicity are difficult to dissect as WASP, the AP-3 complex, Rab27a, Munc13-4 and syntaxin 11 are expressed in a variety of other cell types. Nonetheless, the loss of NK cytotoxicity is likely to make a significant contribution to the pathology of the immune disorders in which these proteins are mutated. HPS2, GS2, FHL-3 and FHL-4 are all characterized by haemophagocytic lymphohistiocytosis, which has also been observed in WAS. [68] [69] [70] Haemophagocytic lymphohistiocytosis is an exaggerated inflammatory response that is normally triggered by viral infection. 68, 69 In the aforementioned disorders NK cells cannot kill the cells that promote the immune response to infection, so the resultant inflammation cannot be resolved and becomes life threatening. 68, 69 Consequently, despite haemophagocytic lymphohistiocytosis being at least partly caused by the loss of cytotoxic function of NK cells, treatment for this condition requires immunosuppressive agents to reduce the inflammatory process.
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Concluding remarks
In recent years much has been learnt about the exocytosis of secretory lysosomes and the essential role of this process in NK cell cytotoxicity. These studies demonstrate that secretory lysosome exocytosis is a tightly regulated and coordinated process. Many of the proteins that facilitate secretory lysosome exocytosis have been identified, with much of this information coming from the study of immune disorders in which NK cell cytotoxicity is impaired. However, more research is required to fully understand this complex molecular process and in particular how it is integrated with the signalling pathways of the multiple NK cell receptors.
